Showing results 1 to 32 of 32
|A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
|Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
|Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads
|Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma
|Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities
|Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling.
|강성운, 김연수, 김철호, 신유섭
|Comparative proteomic analysis of advanced serous epithelial ovarian carcinoma: possible predictors of chemoresistant disease.
|Curcumin inhibits the cancer-associated fibroblast-derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway
|최경숙, 함인혜, 허훈
|Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).
|Deleterious Mechanical Deformation Selects Mechanoresilient Cancer Cells with Enhanced Proliferation and Chemoresistance
|Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.
|김영배, 이광, 조용관, 한상욱, 허훈
|Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL
|김철호, 신유섭, 이복순, 한재호
|Effect of Tissue Transglutaminase on Steroid Resistance in T-Cell Acute Lymphoblastic Leukemia
|박준은, 윤승현, 정현주
|Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.
|EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression
|우현구, 윤사라, 최지혜
|Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
|김명욱, 김효철, 이기범, 임호영, 조용관, 주희재, 최진혁
|Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01)
|Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells
|김보영, 김현주, 임현이, 정선용, 진현석, 한재호
|Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo
|Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells.
|Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors
|Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death
|P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer.
|Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis
|손성향, 윤계순, 최경숙
|Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041)
|Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
|Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis
|김영배, 조혜성, 채선영
|Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin.
|Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma.
|Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
|손상용, 이다근, 최경숙, 한상욱, 함인혜, 허훈
|Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma
|Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancer
|김진홍, 양민재, 유병무, 이현우, 황재철